Press release
Companion Diagnostics Market is Forecasted to Soar at a Stellar 11.4% CAGR from 2024 to 2031 Owing to High Demand for Personalized Medicine and Targeted Therapies
Skyquest Tehnology
Companion Diagnostic Market [https://www.skyquestt.com/report/companion-diagnostics-market] size was valued at USD 6.62 Billion in 2022 and is poised to grow from USD 7.37 Billion in 2023 to USD 17.48 Billion by 2031, growing at a CAGR of 11.4% in the forecast period (2024-2031).
Companion diagnostics refers to a diagnostic test used to identify the applicability of therapeutic drugs to a specific patient. Rising emphasis on personalized medicine on a global level is estimated to primarily augment the demand for companion diagnostics across the study period. Increasing availability and acceptance of novel companion diagnostics products around the world will also augment market growth going forward.
Advancements in genomics and molecular biology are also forecasted to create new business scope for companion diagnostics companies. The rising use of companion diagnostics for the treatment of chronic diseases and their increased prevalence on a global level will also promote market growth over the coming years. The launch of favorable reimbursement policies covering companion diagnostics' expenses is also expected to influentially boost their adoption worldwide. Oncology is expected to remain the most opportune indication for companion diagnostics companies to invest in going forward.
Download a detailed overview:
https://www.skyquestt.com/sample-request/companion-diagnostics-market
Partnerships Estimated to Remain a Preferred Strategy for All Companion Diagnostics Providers
Companion diagnostics companies are projected to heavily invest in the research and development of new products and technologies to improve their revenue generation. Companion diagnostics companies can expedite their research and development cycles by opting for partnerships with other organizations. Companies are also expected to utilize advancements in genomics and personalized medicine to boost their sales potential. Companion diagnostics market players are also anticipated to focus on getting approvals for their products from regulatory bodies.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/companion-diagnostics-market
* Labcorp, a leading name in the life sciences and healthcare space, announced the launch of a new companion diagnostic for Amgen's new therapy back in July 2021. Patients with non-small cell lung cancer (NSCLC) can utilize Labcorp's therascreen Registered KRAS PCR Mutation Analysis to identify treatment potential using Amgen's LUMAKRAS Trademark (sotorasib).
* Boehringer Ingelheim, a leading research-driven pharmaceutical organization joined hands with Illumina Inc. to develop companion diagnostics back in January 2022. The partnership was specifically focusing on the oncology pipeline of Boehringer and intended to accelerate the therapy selection process for patients suffering from highly developed cancer tumors.
* Labcorp's new companion diagnostic for use with Pfizer's new gene therapy was approved by the United States Food and Drug Administration (FDA) in April 2024. nAbCyte Trademark Anti-AAVRh74var HB-FE Assay will help determine the eligibility of Hemophilia B patients to be treated with Pfizer's newly approved gene therapy.
* Roche, a top supplier of pharmaceuticals based out of Switzerland teamed up with PathAI, a top name in the AI-powered pathology business to improve pathology capabilities for companion diagnostics in February 2024. The partnership is expected to help these companies open up new application scope for personalized medicine business going forward.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/companion-diagnostics-market
Personalized medicine use to treat chronic indications will emerge as the top opportunity for companion diagnostics companies going forward. New companies need to come up with high capital investments to fund their R&D efforts as this is a highly capital-intensive market. Established companies will need to target innovation if they wish to stand out in the competitive landscape going forward.
Related Reports:
Edge Computing Market [https://www.skyquestt.com/report/edge-computing-market]
Visit Our Website: https://www.skyquestt.com/
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=companion-diagnostics-market-is-forecasted-to-soar-at-a-stellar-114-cagr-from-2024-to-2031-owing-to-high-demand-for-personalized-medicine-and-targeted-therapies]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/companion-diagnostics-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics Market is Forecasted to Soar at a Stellar 11.4% CAGR from 2024 to 2031 Owing to High Demand for Personalized Medicine and Targeted Therapies here
News-ID: 3605888 • Views: …
More Releases from ABNewswire
Reef Haven Sets New Industry Benchmark for Marine Livestock Safety with Medical …
Reef Haven elevates the Australian marine hobby with rigorous medical quarantine protocols for saltwater fish. Located in Melbourne, this aquarium store offers guaranteed healthy livestock, WYSIWYG corals, and premium supplies. Owner Hazel Lee provides peace of mind to enthusiasts nationwide, delivering disease-free animals and expert maintenance services for thriving reef tanks.
MELBOURNE, Victoria - Reef Haven, a specialist marine aquarium retailer located in Box Hill South, is redefining the standards of…
Full Body Checkup The Gateway to Proactive Health
A full body checkup is one of the most thorough and proactive approaches to taking control of your long-term health. By regularly evaluating all major bodily systems and risk factors, a full body checkup helps to identify potential problems before symptoms develop, granting you the opportunity to stay healthy and empowered. At Liv Hospital [https://int.livhospital.com/], patients benefit from advanced diagnostics, experienced specialists, and patient-centered comfort throughout the process, making routine…
Andy DeFrancesco on Market Cycles, Business Mindset, and the Future of the Busin …
Image: https://www.abnewswire.com/upload/2025/11/d35dbae4dbd114c90cd75748c7d93c3c.jpg
Market optimism rises and falls in waves, but the people who shape industries rarely move with emotion. They study patterns, look beyond the noise, and respond to momentum before the crowd recognizes it. Andy DeFrancesco [https://www.linkedin.com/authwall?trk=bf&trkInfo=AQGgt6lQ4W3QHgAAAZqcxvlI_dUN8oxVB90MzEZ8iE-RruFwmtW1mgWieTjNpqt9TfGmpIboUWLMgp2cCS3U44ppQA-fyWs0h6Op-uvqdNuDq7e6HJhMneocPYkXhKrOLhPDFUM=&original_referer=&sessionRedirect=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fandy-defrancesco-77584930a] has spent his entire career doing exactly that. After decades in public markets, private equity, and emerging sectors, he has learned that the numbers matter - but the psychology behind them matters more.
Business…
The Current Business Landscape: A High-Stakes, Tech-Driven Era
In 2025, the global business environment is shaped by a complex interplay of technology, economic pressures, and evolving market expectations. While inflation and cost control remain real concerns for many companies, digital transformation and cyber risk are dominating boardroom conversations. Business leaders increasingly cite artificial intelligence, cybersecurity, and cost management as their top priorities.
At the same time, the pace of technology adoption continues to accelerate. Small and midsize businesses are…
More Releases for Companion
Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook…
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74…
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors.
The Artificial Intelligence (AI) In Beauty and Cosmetics Market…
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673
This latest report researches the industry structure, sales, revenue,…
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S.
Moreover, the…
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test…
